BOSTON, Jan. 6, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc., a clinical-stage biotechnology company pioneering next-generation bispecific antibodies for immunology & inflammation (I&I), today ...
Current Gaps in Fertility Preservation for Men: How Can We do Better? The article by Ou et al entitled “First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results